Dennis L. Andress

AbbVie (United States) — United States

Medicine · Health Sciences

44h-index8.2kcitations109works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parathyroid Disorders and Treatments(39), Vitamin D Research Studies(19), Trace Elements in Health(18), Aluminum toxicity and tolerance in plants and animals(16), Dialysis and Renal Disease Management(14)

Publications109 total

Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol
BMC Nephrology·2020· 38 citedOpen Access
Prognostic Imaging Biomarkers for Diabetic Kidney Disease (iBEAt): Study protocol
2020· 8 citedOpen Access
Additional file 2 of Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol
Figshare·2020Open Access
Additional file 4 of Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol
Figshare·2020Open Access
Additional file 3 of Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol
Figshare·2020Open Access
Additional file 1 of Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol
Figshare·2020Open Access
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
The Lancet·2019· 590 citedOpen Access
Baseline characteristics and enrichment results from the <scp>SONAR</scp> trial
Diabetes Obesity and Metabolism·2018· 39 citedOpen Access
Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy
Diabetes Obesity and Metabolism·2018· 87 citedOpen Access
Baseline characteristics and enrichment results of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial.
Diabetes Obesity and Metabolism·2018
Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial
Drugs in R&D·2017· 8 citedOpen Access
Relationship Between Atrasentan Concentrations and Urinary Albumin to Creatinine Ratio in Western and Japanese Patients With Diabetic Nephropathy
Clinical Therapeutics·2017· 18 cited
The effects of atrasentan on urinary metabolites in patients with type 2 diabetes and nephropathy
Diabetes Obesity and Metabolism·2016· 26 cited
Comparison of exposure response relationship of atrasentan between <scp>N</scp> orth <scp>A</scp> merican and <scp>A</scp> sian populations
Diabetes Obesity and Metabolism·2016· 5 cited
Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markers
European Journal of Preventive Cardiology·2015· 35 citedOpen Access
Predictors of Atrasentan-Associated Fluid Retention and Change in Albuminuria in Patients with Diabetic Nephropathy
Clinical Journal of the American Society of Nephrology·2015· 37 citedOpen Access
Number and Frequency of Albuminuria Measurements in Clinical Trials in Diabetic Nephropathy
Clinical Journal of the American Society of Nephrology·2015· 25 citedOpen Access
The Endothelin Antagonist Atrasentan Lowers Residual Albuminuria in Patients with Type 2 Diabetic Nephropathy
Journal of the American Society of Nephrology·2014· 290 citedOpen Access
The selective type A endothelin antagonist atrasentan reduces residual albuminuria in patients with type 2 diabetes and nephropathy
Life Sciences·2013· 1 citedOpen Access
Progressive endothelin-1 gene activation initiates chronic/end-stage renal disease following experimental ischemic/reperfusion injury
Kidney International·2013· 106 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Donald J. Sherrard(13), Yili Pritchett(7), Jack W. Coburn(7), Dick de Zeeuw(5), Sheldon W. Tobe(5), Donald E. Kohan(5), Norma A. Maloney(5), David B. Endres(5), Rajiv Agarwal(4), Daniel W. Coyne(4), Hiddo J.L. Heerspink(4), Hirofumi Makino(4), Vlado Perkovic(4), John J. Brennan(4), Paul Audhya(3), George L. Bakris(3), Fan Fan Hou(3), Dalane W. Kitzman(3), John J.V. McMurray(3), Melissa Wigderson(3)